Publications by authors named "Petra Gener"

Claim this Profile
B
Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial.
Joan Albanell, Angelo Gámez Pozo, Carlos L Arteaga, Meritxell Bellet, Federico Rojo, Petra Gener

NPJ Breast Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study.
Alfonso Cortés, Elena López-Miranda, Adela Fernández-Ortega, Vicente Carañana, Sonia Servitja, Petra Gener

Breast· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal [F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial.
Geraldine Gebhart, Marleen Keyaerts, Thomas Guiot, Patrick Flamen, Manuel Ruiz-Borrego, Petra Gener

J Nucl Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing alpelisib-related hyperglycaemia in HR+/HER2-/-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial.
Antonio Llombart-Cussac, José Manuel Pérez-Garcia, Manuel Ruiz Borrego, Pablo Tolosa, Salvador Blanch, Petra Gener

EClinicalMedicine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-year invasive disease-free survival with chemotherapy de-escalation using an F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.
José Manuel Pérez-García, Javier Cortés, Manuel Ruiz-Borrego, Marco Colleoni, Agostina Stradella, Petra Gener

Lancet· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs.
Patricia González-Callejo, Petra Gener, Zamira V Díaz-Riascos, Sefora Conti, Patricia Cámara-Sánchez

Int J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study.
Ana López González, Sonia Del Barco Berrón, Isabel Grau, Maria Galan, Beatriz Castelo Fernández, Petra Gener

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide.
Patricia Cámara-Sánchez, Zamira V Díaz-Riascos, Natalia García-Aranda, Petra Gener, Joaquin Seras-Franzoso

Int J Mol Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pluronic F127 micelles improve the stability and enhance the anticancer stem cell efficacy of citral in breast cancer.
Marwa M Abu-Serie, Fernanda Andrade, Patricia Cámara-Sánchez, Joaquin Seras-Franzoso, Diana Rafael, Petra Gener

Nanomedicine (Lond)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics.
Anna Ulldemolins, Joaquin Seras-Franzoso, Fernanda Andrade, Diana Rafael, Ibane Abasolo, Petra Gener

Cancer Drug Resist· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of nanomedicine to alter cancer stem cell dynamics: the impact of extracellular vesicles.
Petra Gener, Patricia Gonzalez Callejo, Joaquín Seras-Franzoso, Fernanda Andrade, Diana Rafael

Nanomedicine (Lond)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular Vesicles as Drug Delivery Systems in Cancer.
Laia Hernandez-Oller, Joaquin Seras-Franzoso, Fernanda Andrade, Diana Rafael, Ibane Abasolo, Petra Gener

Pharmaceutics· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells.
Petra Gener, Sara Montero, Helena Xandri-Monje, Zamira V Díaz-Riascos, Diana Rafael

Nanomedicine· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug Delivery in Triple-Negative Breast Cancer Stem Cells.
Mireia Pesarrodona, Laura Sánchez-García, Joaquin Seras-Franzoso, Alejandro Sánchez-Chardi, Ricardo Baltá-Foix, Petra Gener

ACS Appl Mater Interfaces· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pivotal Role of AKT2 during Dynamic Phenotypic Change of Breast Cancer Stem Cells.
Petra Gener, Diana Rafael, Joaquin Seras-Franzoso, Anna Perez, Luis Alamo Pindado

Cancers (Basel)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells.
Diana Rafael, Petra Gener, Fernanda Andrade, Joaquin Seras-Franzoso, Sara Montero

Drug Deliv· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells.
Petra Gener, Joaquin Seras-Franzoso, Patricia González Callejo, Fernanda Andrade, Diana Rafael

Stem Cells Int· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-assembly PEGylation assists SLN-paclitaxel delivery inducing cancer cell apoptosis upon internalization.
Alexandra Arranja, Luís F Gouveia, Petra Gener, Diana F Rafael, Carolina Pereira

Int J Pharm· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer stem cells and personalized cancer nanomedicine.
Petra Gener, Diana Fernandes de Sousa Rafael, Yolanda Fernández, Joan Sayós Ortega, Diego Arango

Nanomedicine (Lond)· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells.
Petra Gener, Luis Pleno Gouveia, Guillem Romero Sabat, Diana Fernandes de Sousa Rafael, Núria Bergadà Fort

Nanomedicine· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin.
Fernanda Andrade, José das Neves, Petra Gener, Simó Schwartz, Domingos Ferreira

Nanomedicine· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracellular targeting of CD44+ cells with self-assembling, protein only nanoparticles.
Mireia Pesarrodona, Neus Ferrer-Miralles, Ugutz Unzueta, Petra Gener, Witold Tatkiewicz

Int J Pharm· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis